Glioblastoma multiforme metastastic to the bone: diagnosis by (18)F-NaF PET/CT.

@article{Derlin2014GlioblastomaMM,
  title={Glioblastoma multiforme metastastic to the bone: diagnosis by (18)F-NaF PET/CT.},
  author={Thorsten Derlin and Till Sebastian Clauditz and Peter Bannas},
  journal={Clinical nuclear medicine},
  year={2014},
  volume={39 2},
  pages={
          188-9
        }
}
Extracranial metastases from glioblastoma multiforme (GBM) are rare. We report a case of osseous metastases from GBM diagnosed by F-NaF PET/CT. A 30-year-old man with a history of GBM presented with bone pain and underwent F-NaF PET/CT for further evaluation. On PET/CT, intense uptake in 2 bone lesions was noted. Histopathologic evaluation revealed osseous metastases from GBM. Although rare, bone metastases have to be considered in patients with axial tumors and atraumatic bone pain. F-NaF PET… 
View on PubMed
brainlife.org
3 Citations

3 Citations

Citation Type

Citation Type

Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature
TLDR
Two YKL-40-positive GBM patients with extra-CNS (central nervous system) metastases are described and a meta-analysis of 94 cases supports the idea that prolonged survival of G BM patients increases the probability of GBM cells shedding to lymphatic and hematic system.
Non-routine Tracers for PET Imaging of High-grade Glioma.
TLDR
Recently employed PET tracers designed for the non-routine investigation of specific aspects of HGG metabolism, including hypoxia, neoangiogenesis, expression of integrins and stem cell markers, are reviewed.
Erratum to: Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature
TLDR
Two YKL-40-positive GBM patients with extra-CNS (central nervous system) metastases are described and a meta-analysis of 94 cases supports the idea that prolonged survival of G BM patients increases the probability of GBM cells shedding to lymphatic and hematic system.

References

SHOWING 1-10 OF 11 REFERENCES
Bone marrow metastases from glioblastoma multiforme – A case report and review of the literature
TLDR
A 60-year-old man with GBM who developed back pain, thrombocytopenia and subsequently neurological deficits was found to have extensive bony and bone marrow metastases, and the case of a patient developing systemic dissemination of a GBM is described.
Detection of multiple extracranial metastases from glioblastoma multiforme by means of whole-body [18F]FDG-PET
TLDR
Results demonstrate that [F]FDG-PET is a valuable tool for diagnostic work-up and oncological screening in patients with suspected metastatic lesions from glioblastoma multiforme.
Diffuse vertebral body metastasis from a glioblastoma multiforme: a technetium-99m Sestamibi single-photon emission computerized tomography study.
TLDR
In patients with malignant glioma and lower-back pain, bone metastasis, although uncommon, does occasionally occur and its possibility should be investigated; a MIBI SPECT study may prove useful in this regard.
Multiple Bone Metastases in a Patient with Glioblastoma Multiforme
TLDR
A case of glioblastoma multiforme with distant osseous metastases that were detected by a Tc-99m MDP image and were osteolytic and expansile on plain radiographs.
Differentiation of Newly Diagnosed Glioblastoma Multiforme and Intracranial Diffuse Large B-cell Lymphoma Using 11C-Methionine and 18F-FDG PET
TLDR
Both SUVmax on FDG PET and &Dgr;SUVmax on MET-PET were considered to be good diagnostic tests when encountering difficulties in this differential diagnosis of glioblastoma multiforme and intracranial diffuse large B-cell lymphoma.
Clinical Applications of PET in Brain Tumors*
  • Wei Chen
  • Medicine
    Journal of Nuclear Medicine
  • 2007
TLDR
The sensitivity and specificity of 18F-FDG in evaluating recurrent tumor and treatment-induced changes can be improved significantly by coregistration with MRI and potentially by delayed imaging 3–8 h after injection.
Comparison of F-18 FDG and C-11 Methionine PET/CT for the Evaluation of Recurrent Primary Brain Tumors
TLDR
MET should be the radiotracer of choice in the evaluation of recurrence of primary brain tumors because the sensitivity for detection and delineation of the possible recurrent tumor, as well as secondary deposits, is higher with MET.
Usefulness of whole-body (18)F-FDG PET in patients with suspected metastatic brain tumors.
TLDR
Screening the patients with suspected metastatic brain tumors using whole-body (18)F-FDG PET could be helpful in differentiating metastatic head tumor from primary brain tumor and in detecting the primary lesion.
Atlas of sodium fluoride PET bone scans: atlas of NaF PET bone scans.
TLDR
It is believed that NaF positron emission tomography/computed tomography bone scans can provide a more thorough and conclusive evaluation of bone diseases than conventional Technetium-99m-methylene diphosphonate bone scans.
Lack of concordance between the F-18 fluoromisonidazole PET and the F-18 FDG PET in human glioblastoma.
A 57-year-old man with an unresectable glioblastoma had both F-18 fluorodeoxyglucose and F-18 fluoromisonidazole positron emission tomography coupled with computerized tomography before radiotherapy.…
...
1
2
...